PharmX Technologies Limited (ASX:PHX)
Australia · Delayed Price · Currency is AUD 0.1150
+0.0050 (4.55%)
At close: Aug 28, 2025
PharmX Technologies Revenue
In the fiscal year ending June 30, 2025, PharmX Technologies had annual revenue of 7.53M AUD, down -6.97%. PharmX Technologies had revenue of 3.76M in the half year ending June 30, 2025, with 23.38% growth.
Revenue
7.53M
Revenue Growth
-6.97%
P/S Ratio
9.14
Revenue / Employee
69.08K
Employees
109
Market Cap
68.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.53M | -564.00K | -6.97% |
| Jun 30, 2024 | 8.09M | 1.97M | 32.10% |
| Jun 30, 2023 | 6.13M | 742.00K | 13.78% |
| Jun 30, 2022 | 5.39M | -6.49M | -54.65% |
| Jun 30, 2021 | 11.88M | 1.23M | 11.58% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.85B |
| Telix Pharmaceuticals | 1.01B |
| Ansell | 3.06B |
| Mesoblast | 26.23M |